tRF-Leu reverse breast cancer cells chemoresistance by regulation of BIRC5
We demonstrated that tRF-Leu could inhibit the chemotherapy resistance of breast cancer by targeting BIRC5. These findings might identify new biomarkers of breast cancer therapy and bring new strategies to reverse chemotherapy resistance.
Authors
- Yuwen Jiao (ORCID: https://orcid.org/0000-0001-9417-4279)
- Li Sun
- Donglin Sun (ORCID: https://orcid.org/0000-0002-9503-1920)
- Fu-Qi Cui
- Zhong-Ya Xu
- Jin Liu (ORCID: https://orcid.org/0000-0002-6485-1985)
Institutions
- Dalian Medical University (CN)
- Soochow University (CN)
- Nanjing Children's Hospital (CN)
- Changzhou No.2 People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-09-15
- DOI
- https://doi.org/10.1007/s12672-024-01317-1
- Citations
- 1
- Primary Topic
- Cell death mechanisms and regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.23